12 Results for "

BLT2

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "BLT2" in MCE Product Catalog:

  • Isoforms Recommended:
3
3 Cited Publications
Cat. No.: HY-15744
CAS No.: 117690-79-6
Purity:  98.52%
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology Cancer

LY255283 is a LTB4 receptor (BLT2) antagonist, with an IC50 of ~100 nM for [ 3H]LTB4 binding to guinea pig lung membranes [2] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113330
CAS No.: 54397-84-1
Purity:  98.40%
Synonyms: 12(S)-HHTrE
12S-HHT (12(S)-HHTrE) is an enzymatic product of prostaglandin H2 (PGH2) derived from cyclooxygenase (COX)-mediated arachidonic acid metabolism. 12S-HHT is an endogenous ligand for BLT2 that fully activates BLT2 in vivo. 12S-HHT suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity [2].
loading...
    loading...
Cat. No.: HY-155300
CAS No.: 2069220-61-5
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

BLT2 antagonist-1 (compound 15b) is a selective BLT2 antagonist that inhibits the chemotaxis of CHO-BLT2 cells with an IC50 of 224 nM. BLT2 antagonist-1 does not inhibits the chemotaxis of CHO-BLT1 cells. BLT2 antagonist-1 also inhibits the binding of LTB4 and BLT2 with a Ki value of 132 nM. BLT2 antagonist-1 can be used for the research of the inflammatory airway diseases such as asthma and chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-122124
CAS No.: 862891-27-8
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

CAY10583 is a potent and selective full Leukotriene B4 receptor type 2 (BLT2) agonist. CAY10583 directly promotes keratinocyte migration in vitro and accelerates wound closure in vivo. CAY10583 is a promising pharmaceutical agent for diabetic wounds .
loading...
    loading...
Cat. No.: HY-W002908
CAS No.: 374538-03-1
2-Methoxycarbonylphenylboronic acid is an intermediate. 2-Methoxycarbonylphenylboronic acid can be used in the synthesis of BLT2 agonist .
loading...
    loading...
Cat. No.: HY-142521
CAS No.: 2893803-05-7
Target:  

Leukotriene Receptor

Research Areas:  

Metabolic Disease

BLT2 probe 1 (compound 13) is a fluorescent probe based on the synthetic BLT2 agonist CAY10583. BLT2 is a promising target for diabetic wound healing and gastrointestinal lesions. BLT2 probe 1 is suitable to investigate the pharmacology of BLT2 receptor ligands in a variety of assay systems .
loading...
    loading...
Cat. No.: HY-122175
CAS No.: 162362-36-9
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

ZK-158252 is a leukotriene B4 type-2 receptor (BLT2) antagonist .
loading...
    loading...
Cat. No.: HY-168484
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

T-10430 is a potent and orally active leukotriene B4 receptor 2 (BLT2) agonist. T-10430 has the potential for the research of psoriasis .
loading...
    loading...
Cat. No.: HY-115390
CAS No.: 114616-11-4
14,15-Dehydro Leukotriene B4 (Compound 4) is a LTB4 receptor antagonist. 14,15-Dehydro Leukotriene B4 also has a higher binding affinity for BLT1 with a Ki value of 27 nM and BLT2 with a Ki value of 473 nM. 14,15-Dehydro Leukotriene B4 inhibits LTB4-induced release of lysozymes from rat polymorphonuclear leukoctyes with an IC50 value of 1 µM [2].
loading...
    loading...
Cat. No.: HY-137350
CAS No.: 83709-73-3
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

12-epi-LTB4 is an agonist for BLT1 and BLT2. 12-epi LTB4 exhibits a partial agonistic activity against mBLT1 and mBLT2, and induces phosphorylation of extracellular signal-regulated kinase in primary mouse keratinocytes [2].
loading...
    loading...
Cat. No.: HY-RS07876
Research Areas:  

Others

LTB4R2 Human Pre-designed siRNA Set A contains three designed siRNAs for LTB4R2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-181809
BLT1-IN-1 is an orally active and selective BLT1 inhibitor with an IC50 of 8.7 nM and a Kd of 121 nM. BLT1-IN-1 exerts protective effects against acute lung injury and sepsis in in vivo models. BLT1-IN-1 can be used in research related to acute lung injury and sepsis .
loading...
    loading...
  • 1